Effects of CharcoCaps® (Activated Charcoal) vs. Placebo on Intestinal Gas Production
1 other identifier
interventional
20
1 country
1
Brief Summary
Consumption of a high-fiber diet, often consisting of beans and vegetables, is recommended for improvements in overall health. Unfortunately, intake of the above-mentioned foods is often associated with a significant increase in intestinal gas production. In addition to gas, abdominal bloating, cramping, and associated symptoms can prove unacceptable-leading people to limit or abandon the consumption of bean-rich meals. In an attempt to reduce gas formation and the ensuing symptoms, various anti-gas products have been developed and are sold on the market. One such non-prescription product is Beano, a solution of the enzyme alpha-galactosidase. In addition to alpha-galactosidase, activated charcoal has also been used successfully in some, but not all, studies and may be a good option for certain individuals. CharcoCaps® is a branded form of activated charcoal that has been sold for several years.That said, no controlled studies have been conducted using CharcoCaps®. This study will investigate the effects of ingesting CharcoCaps® before and following the meal on the amount of gas produced, the number of flatus events, and associated symptoms of GI distress during the 6-hour post meal ingestion period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 30, 2021
CompletedFirst Submitted
Initial submission to the registry
December 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 22, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2021
CompletedFirst Posted
Study publicly available on registry
August 22, 2022
CompletedAugust 22, 2022
August 1, 2022
3 months
December 8, 2021
August 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (33)
Breath Hydrogen
Hydrogen measured in exhale using H2 Check Analyzer
0 minutes before chili meal consumed (baseline)
Breath Hydrogen
Hydrogen measured in exhale using H2 Check Analyzer
30 minutes post meal consumption
Breath Hydrogen
Hydrogen measured in exhale using H2 Check Analyzer
60 minutes post meal consumption
Breath Hydrogen
Hydrogen measured in exhale using H2 Check Analyzer
90 minutes post meal consumption
Breath Hydrogen
Hydrogen measured in exhale using H2 Check Analyzer
120 minutes post meal consumption
Breath Hydrogen
Hydrogen measured in exhale using H2 Check Analyzer
150 minutes post meal consumption
Breath Hydrogen
Hydrogen measured in exhale using H2 Check Analyzer
180 minutes post meal consumption
Breath Hydrogen
Hydrogen measured in exhale using H2 Check Analyzer
210 minutes post meal consumption
Breath Hydrogen
Hydrogen measured in exhale using H2 Check Analyzer
240 minutes post meal consumption
Breath Hydrogen
Hydrogen measured in exhale using H2 Check Analyzer
270 minutes post meal consumption
Breath Hydrogen
Hydrogen measured in exhale using H2 Check Analyzer
300 minutes post meal consumption
Breath Hydrogen
Hydrogen measured in exhale using H2 Check Analyzer
330 minutes post meal consumption
Breath Hydrogen
Hydrogen measured in exhale using H2 Check Analyzer
360 minutes post meal consumption
Gastrointestinal Symptoms Questionnaire
Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort
baseline
Gastrointestinal Symptoms Questionnaire
Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort
30 minutes post meal consumption
Gastrointestinal Symptoms Questionnaire
Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort
60 minutes post meal consumption
Gastrointestinal Symptoms Questionnaire
Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort
90 minutes post meal consumption
Gastrointestinal Symptoms Questionnaire
Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort
120 minutes post meal consumption
Gastrointestinal Symptoms Questionnaire
Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort
150 minutes post meal consumption
Gastrointestinal Symptoms Questionnaire
Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort
180 minutes post meal consumption
Gastrointestinal Symptoms Questionnaire
Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort
210 minutes post meal consumption
Gastrointestinal Symptoms Questionnaire
Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort
240 minutes post meal consumption
Gastrointestinal Symptoms Questionnaire
Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort
270 minutes post meal consumption
Gastrointestinal Symptoms Questionnaire
Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort
300 minutes post meal consumption
Gastrointestinal Symptoms Questionnaire
Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort
330 minutes post meal consumption
Gastrointestinal Symptoms Questionnaire
Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort
360 minutes post meal consumption
Flatus events
Self-reported number of flatus events each hour
baseline
Flatus events
Self-reported number of flatus events each hour
60 minutes post meal consumption
Flatus events
Self-reported number of flatus events each hour
120 minutes post meal consumption
Flatus events
Self-reported number of flatus events each hour
180 minutes post meal consumption
Flatus events
Self-reported number of flatus events each hour
240 minutes post meal consumption
Flatus events
Self-reported number of flatus events each hour
300 minutes post meal consumption
Flatus events
Self-reported number of flatus events each hour
360 minutes post meal consumption
Secondary Outcomes (1)
Concluding Questionnaire
60 minutes post meal consumption
Study Arms (2)
Charcocaps
EXPERIMENTAL2 capsules 15 minutes before meal and 2 additional capsules 2 hours after meal
Placebo
PLACEBO COMPARATOR2 capsules 15 minutes before meal and 2 additional capsules 2 hours after meal
Interventions
250 mg capsules containing Activated charcoal, Gelatin, Titanium Dioxide, and Carmine
Eligibility Criteria
You may qualify if:
- Self-report of at least one of the following symptoms after eating meals rich in complex carbohydrates (such as beans):
- Abdominal bloating/pain/cramps
- Flatulence/gas
- Willing to consume a meatless chili meal and steamed broccoli
- No consumption of alcohol-containing beverages within 24 hours of testing
- No consumption of caffeine-containing beverages within 24 hours of testing
- No strenuous exercise within 24 hours of testing
- Be able to fast overnight (\>10 hrs)
You may not qualify if:
- Diagnosed GI condition
- Diabetic
- Pregnant/lactating
- Self-reported active infection or illness of any kind
- Tobacco product user
- Hypersensitivity or allergy to any component of the supplement or chili (Activated charcoal, Gelatin, Titanium Dioxide, and Carmine, black beans, kidney beans, pinto beans, tomato puree, bell peppers, onion, sweet potato, chili powder, onion powder, garlic powder, salt, pepper, cumin, oregano, broccoli)
- Taking any anti-gas, or anti-flatulence medication or dietary supplements, or if taking only non-prescribed supplements/mediations, not willing to cease use of them during study period
- A regular consumer of bean meals (no more than once weekly)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Memphislead
- DSE Healthcare Solutionscollaborator
Study Sites (1)
Center for Nutraceutical and Dietary Supplement Research
Memphis, Tennessee, 38152, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Bloomer, PhD
University of Memphis
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Charcocaps and placebo capsules are similar in appearance and provided to investigators pre-masked (A and B).
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dean of the College of Health Sciences
Study Record Dates
First Submitted
December 8, 2021
First Posted
August 22, 2022
Study Start
September 30, 2021
Primary Completion
December 22, 2021
Study Completion
December 22, 2021
Last Updated
August 22, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share